Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$12.93 - $17.17 $1.26 Million - $1.67 Million
-97,411 Reduced 71.4%
39,024 $541,000
Q2 2022

Aug 15, 2022

BUY
$13.53 - $23.34 $1.62 Million - $2.8 Million
119,975 Added 728.89%
136,435 $1.96 Million
Q1 2022

May 16, 2022

SELL
$16.14 - $22.6 $2.11 Million - $2.95 Million
-130,440 Reduced 88.8%
16,460 $372,000
Q4 2021

Feb 14, 2022

BUY
$18.64 - $36.77 $2.54 Million - $5.01 Million
136,120 Added 1262.71%
146,900 $2.76 Million
Q3 2021

Nov 15, 2021

BUY
$32.83 - $43.0 $353,907 - $463,540
10,780 New
10,780 $354,000
Q1 2021

May 17, 2021

SELL
$37.29 - $47.19 $263,565 - $333,538
-7,068 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$34.3 - $44.09 $127,184 - $163,485
-3,708 Reduced 34.41%
7,068 $309,000
Q3 2020

Nov 16, 2020

SELL
$27.86 - $39.35 $804,206 - $1.14 Million
-28,866 Reduced 72.82%
10,776 $424,000
Q2 2020

Aug 17, 2020

BUY
$30.3 - $42.55 $183,678 - $257,938
6,062 Added 18.05%
39,642 $1.25 Million
Q1 2020

May 15, 2020

BUY
$30.0 - $54.18 $92,820 - $167,632
3,094 Added 10.15%
33,580 $1.18 Million
Q4 2019

Feb 14, 2020

BUY
$42.29 - $52.2 $1.08 Million - $1.33 Million
25,450 Added 505.36%
30,486 $1.48 Million
Q3 2019

Nov 14, 2019

SELL
$42.06 - $51.64 $1.97 Million - $2.41 Million
-46,729 Reduced 90.27%
5,036 $239,000
Q2 2019

Aug 14, 2019

BUY
$33.93 - $43.66 $1.76 Million - $2.26 Million
51,765 New
51,765 $2.22 Million
Q1 2019

May 15, 2019

SELL
$26.74 - $41.32 $775,968 - $1.2 Million
-29,019 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$25.26 - $38.43 $120,439 - $183,234
4,768 Added 19.66%
29,019 $827,000
Q3 2018

Nov 01, 2018

BUY
$33.27 - $39.25 $513,688 - $606,020
15,440 Added 175.24%
24,251 $949,000
Q2 2018

Aug 03, 2018

BUY
$21.73 - $33.15 $191,463 - $292,084
8,811 New
8,811 $285,000

Others Institutions Holding CSII

About Cardiovascular Systems Inc


  • Ticker CSII
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 41,905,900
  • Description
  • Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...
More about CSII
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.